Protalix BioTherapeutics
PLX
PLX
65 hedge funds and large institutions have $6.58M invested in Protalix BioTherapeutics in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+3
Holders Change %
+4.84%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
12
Reduced
16
Closed
23
Calls
$125K
Puts
$5K
Net Calls
+$120K
Net Calls Change
+$75K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$949K |
| 2 |
2
Goldman Sachs
New York
|
$540K |
| 3 |
3
Jane Street
New York
|
$340K |
| 4 |
YIH
4
Y-Intercept (HK)
Hong Kong
|
$185K |
| 5 |
CC
5
Centiva Capital
New York
|
$152K |
